Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Emdogain and autogenous bone graft in chronic periodontitis
NCT02218515Phase 4Completed
- Start
- Sep 2010
- Primary completion
- Sep 2012
- Modality
- Biologic, rProtein (Recombinant Protein)
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of enamel matrix derivative in chronic periodontitis. Started Sep 2010; status: completed.
02
Drugs
enamel matrix derivative
03
Conditions
chronic periodontitis
Beyond the preview
Go deeper on NCT02218515.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02218515.